EFTA00304870.pdf

Report Status: Final Quest Diagnostics EPSTEIN, JEFFREY Patient Information Specimen Information Clientheonnation Specimen: MR047985L Client #: 78300020 56W5265 EPSTEIN, JEFFREY Requisition: 0006030 MOSKOWITZ,BRUCE W DOB: 01/20/1953 AGE: 65 BRUCE MOSKOWITZ,MD Gender: M Attn: NATIONWIDE ACCOUNT Collected: 08/14/2018 Phone: 1411 N FLAGLER DR STE 7100 Received: 08/15/2018 15:11 EDT Patient ID: 19530120MJE WEST PALM BEACH,FL 33401-3418 Reported: 08/16/2018 14:56 EDT Health ID: 8573003290851249 Test Name In Range Out Of Range Reference Range Lab LIPID PANEL, STANDARD CHOLESTEROL, TOTAL 233 H <200 mg/dL MI HDL CHOLESTEROL 29 L >40 mg/dL MI TRIGLYCERIDES 541 H <150 mg/dL MI LDL-CHOLESTEROL mg/dL (calc) MI LDL cholesterol not calculated. Triglyceride levels greater than 400 mg/dL invalidate calculated LDL results. Reference range: <100 Desirable range <100 mg/dL for primary prevention; <70 mg/dL for patients with CHD or diabetic patients with > or = 2 CHD risk factors. LDL-C is now calculated using the Martin-Hopkins calculation, which is a validated novel method providing better accuracy than the Friedewald equation in the estimation of LDL-C. Martin SS et al. JAMA. 2013;310(19): 2061-2068 (http://education.QuestDiagnostics.com/faq/FAQ164) CHOL/HDLC RATIO 8.0 H <5.0 (calc) MI NON HDL CHOLESTEROL 204 H <130 mg/dL (calc) MI For patients with diabetes plus 1 major ASCVD risk factor, treating to a non-HDL-C goal of <100 mg/dL (LDL-C of <70 mg/dL) is considered a therapeutic option. HS CRP 1.3 mg/L TP Average relative cardiovascular risk according to AHA/CDC guidelines. For ages >17 Years: hs-CRP mg/L Risk According to AHA/CDC Guidelines <1.0 Lower relative cardiovascular risk. 1.0-3.0 Average relative cardiovascular risk. 3.1-10.0 Higher relative cardiovascular risk. Consider retesting in 1 to 2 weeks to exclude a benign transient elevation in the baseline CRP value secondary to infection or inflammation. >10.0 Persistent elevation, upon retesting, may be associated with infection and inflammation. HONOCYSTEINE 20.5 H <11.4 umol/L MI Homocysteine is increased by functional deficiency of folate or vitamin B12. Testing for methylmalonic acid differentiates between these deficiencies. Other causes of increased homocysteine include renal failure, folate antagonists such as methotrexate and phenytoin, and exposure to nitrous oxide. CLIENT SERVICES:866.697.8378 SPECIMEN: MR047985L PAGE I OF5 Quest. Quest Diagnostics, the associated logo and all associated Quest Diagnostics marks are the trademarks of Quest Diagnostics. EFTA00304870  Report Status: Final raj -00 Quest Diagnostics' EPSTEIN, JEFFREY Patient Information Specimen Information Client Information Specimen: MR047985L Client #: 78300020 EPSTEIN, JEFFREY Collected: 08/14/2018 MOSKOWITZ. BRUCE W DOB: 01/20/1953 AGE: 65 Received: 08/15/2018 / 15:11 EDT Gender: M Reported: 08/16/2018 / 14:56 EDT Patient ID: 19530120MJE Health ID: 8573003290851249 Test Name In Range Out Of Range Reference Range Lab COMPREHENSIVE METABOLIC MI PANEL GLUCOSE 95 65-99 mg/dL Fasting reference interval UREA NITROGEN (BUN) 21 7-25 mg/dL CREATININE 1.16 0.70-1.25 mg/dL For patients >49 years of age, the reference limit for Creatinine is approximately 13% higher for people identified as African-American. eGFR NON-AFR. AMERICAN 66 > OR = 60 mL/min/1.73m2 eGFR AFRICAN AMERICAN 76 > OR = 60 mL/min/1.73m2 BUN/CREATININE RATIO NOT APPLICABLE 6-22 (calc) SODIUM 139 135-146 mmol/L POTASSIUM 4.4 3.5-5.3 mmol/L CHLORIDE 105 98-110 mmol/L CARBON DIOXIDE 23 20-32 mmol/L CALCIUM 9.8 8.6-10.3 mg/dL PROTEIN, TOTAL 7.0 6.1-8.1 g/dL ALBUMIN 4.2 3.6-5.1 g/dL GLOBULIN 2.8 1.9-3.7 g/dL (calc) ALBUMIN/GLOBULIN RATIO 1.5 1.0-2.5 (calc) BILIRUBIN, TOTAL 0.8 0.2-1.2 mg/dL ALKALINE PHOSPHATASE 55 40-115 U/L AST 23 10-35 U/L ALT 35 9-46 U/L HEMOGLOBIN Ale 5.7 H <5.7 % of total Hgb MI For someone without known diabetes, a hemoglobin Alc value between 5.7% and 6.4% is consistent with prediabetes and should be confirmed with a follow-up test. For someone with known diabetes, a value <7% indicates that their diabetes is well controlled. Alc targets should be individualized based on duration of diabetes, age, comorbid conditions, and other considerations. This assay result is consistent with an increased risk of diabetes. Currently, no consensus exists regarding use of hemoglobin Alc for diagnosis of diabetes for children. URIC ACID 8.3 H 4.0-8.0 mg/dL MI Therapeutic target for gout patients: <6.0 mg/dL TSH 2.31 0.40-4.50 mIU/L MI T4 (THYROXINE), TOTAL 7.9 4.9-10.5 mcg/dL MI FREE T4 INDEX (T7) 2.4 1.4-3.8 T3 UPTAKE 30 22-35 % MI SED RATE BY MODIFIED MI CLIENTSERIIICES:866.6971378 SPECIMEN: MR047985L PAGE 2OF 5 Quest. Quest Diagnostics, the associated logo and all associated Quest Diagnostics marks are the trademarks of Quest Diagnostics. EFTA00304871  Report Status: Final raj Quest Diagnostics EPSTEIN, JEFFREY Patient Information Specimen Information Client Information Specimen: MR047985L Client #: 78300020 EPSTEIN, JEFFREY Collected: 08/14/2018 MOSKOWITZ, BRUCE W DOB: 01/20/1953 AGE: 65 Received: 08/15/2018 / 15:11 EDT Gender: M Reported: 08/16/2018 / 14:56 EDT Patient ID: 19530120MJE Health ID: 8573003290851249 Test Name In Range Out Of Range Reference Range Lab WESTERGREN 9 < OR = 20 mm/h CBC (INCLUDES DIFF/PLT) MI WHITE BLOOD CELL COUNT 5.9 3.8-10.8 Thousand/uL RED BLOOD CELL COUNT 5.12 4.20-5.80 Million/uL HEMOGLOBIN 15.1 13.2-17.1 g/dL HEMATOCRIT 44.5 38.5-50.0 % MCV 86.9 80.0-100.0 fL MCH 29.5 27.0-33.0 pg MCHC 33.9 32.0-36.0 g/dL RDW 13.8 11.0-15.0 % PLATELET COUNT 248 140-400 Thousand/uL MPV 9.7 7.5-12.5 fL ABSOLUTE NEUTROPHILS 2879 1500-7800 cells/uL ABSOLUTE LYMPHOCYTES 2018 850-3900 cells/uL ABSOLUTE MONOCYTES 502 200-950 cells/uL ABSOLUTE EOSINOPHILS 443 15-500 cells/uL ABSOLUTE BASOPHILS 59 0-200 cells/uL NEUTROPHILS 48.8 LYMPHOCYTES 34.2 MONOCYTES 8.5 EOSINOPHILS 7.5 BASOPHILS 1.0 URINALYSIS, COMPLETE MI See Endnote 2 VITAMIN B12 373 200-1100 pg/mL MI Please Note: Although the reference range for vitamin B12 is 200-1100 pg/mL, it has been reported that between 5 and 10% of patients with values between 200 and 400 pg/mL may experience neuropsychiatric and hematologic abnormalities due to occult B12 deficiency; less than 1% of patients with values above 400 pg/mL will have symptoms. C-REACTIVE PROTEIN 1.6 <8.0 mg/L MI MERCURY, BLOOD <5 <OR=10 mcg/L AT This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by the FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes. EXTRA BLUE-TOP TUBE MI AN EXTRA SPECIMEN WAS RECEIVED WITH NO TEST REQUESTED. THE SPECIMEN WILL BE MAINTAINED IN STORAGE IN CASE ADDITIONAL TESTING IS NEEDED. PLEASE CALL THE CLIENT SERVICE DEPARTMENT FOR FURTHER ASSISTANCE. PROLACTIN 3.9 2.0-18.0 ng/mL MI TESTOSTERONE, TOTAL MI MALES (ADULT), IA TESTOSTERONE, TOTAL, MALES (ADULT), IA 150 L 250-827 ng/dL In hypogonadal males, Testosterone, Total, LC/MS/MS, is the recommended assay due to the diminished accuracy of immunoassay at levels below 250 ng/dL. This test code (15983) must be collected in a CLIENT SERVICES: 866.697.8378 SPECIMEN: MR047985L PAGE30F5 Quest. Quest Diagnostics, the associated logo and all associated Quest Diagnostics marks are the trademarks of Quest Diagnostics. EFTA00304872  Report Status: Final raj —00 Quest Diagnostics' EPSTEIN, JEFFREY Patient Information Specimen Information Client Information Specimen: MR047985L Client #: 78300020 EPSTEIN, JEFFREY Collected: 08/14/2018 M0SK0WITZ. BRUCE W DOB: 01/20/1953 AGE: 65 Received: 08/15/2018 / 15:11 EDT Gender: M Reported: 08/16/2018 / 14:56 EDT Patient ID: 19530120MJE Health ID: 8573003290851249 Test Name In Range Out Of Range Reference Range Lab red-top tube with no gel. Endnote I * Test not performed. * * No specimen received. * CLIENT SERVICES: 866.697.8378 SPECIMEN: MR047985L PAGE 4 OF 5 Quest. Quest Diagnostics, the associated logo and all associated Quest Diagnostics marks are the trademarks of Quest Diagnostics. EFTA00304873  Report Status: Final Quest Diagnostics EPSTEIN, JEFFREY Patient Information Specimen Information Client Information Specimen: MR047985L Client #: 78300020 EPSTEIN, JEFFREY Collected: 08/14/2018 MOSKOWITZ, BRUCE W DOB: 01/20/1953 AGE: 65 Received: 08/15/2018 I 15:11 EDT Gender: M Reported: 08/16/2018 I 14:56 EDT Patient ID: 19530120MJE Health ID: 8573003290851249 Endocrinology Test Name Result Reference Range Lab VITAMIN D,25-OH,TOTAL,IA 32 30-100 ng/mL MI Vitamin D Status 25-OH Vitamin D: Deficiency: <20 ng/mL Insufficiency: 20 - 29 ng/mL Optimal: > or = 30 ng/mL For 25-OH Vitamin D testing on patients on D2-supplementation and patients for whom quantitation of D2 and D3 fractions is required, the QuestAssureD(TM) 25-OH VIT D, (D2,D3), LC/MS/MS is recommended: order code 92888 (patients >2yrs). For more information on this test, go to: http://education.questdiagnostics.com/faq/FAQ163 (This link is being provided for informational/ educational purposes only.) Physician Comments: PERFORMING SITE: AT QUEST DIAGNOSTICS.ATLANTA. 1777 MONTMEAL CIRCLE.11JCICER. GA 30084-6S02 Laboratocy Duccior ANDREW N YOUNG.MD.PIID.CLIA: I I D0255931 MI QUIST DIAGNOSTICS-MIAML 1two COMMERCE PARKWAY. MIRAMAR. FL 33015.3938 Laboratory DIrector GLEN L NORM MD PHD. CL1A: 10110277312 TP QUEST DIAGNOSTICS-TAMPA. 4225 E FOWLER AVE TAMPA. FL 33617.2026 Laboratory Duector GLEN L CL1A: 10110291120 CLIENT SERVICES: 866.697.8378 SPECIMEN: MR047985L PAGE 5 OF 5 Quest. Quest Diagnostics, the associated logo and all associated Quest Diagnostics marks are the trademarks of Quest Diagnostics. EFTA00304874